Dr. Ehud Cohen
, Biochemistry & Molecular Biology, IMRIC
My work at IMRIC stems from my childhood interest in science. As a child I would attend after-school activities at The Weizmann Institute near my house, which got me interested in science. This continued through high school. After my military service, I began to study biology and oceanography, but ultimately I found the study of genetics and genetic manipulation really cool.
I did my Masters work at Hebrew University on genetic regulation of viruses and later focused on cell biology. At IMRIC, my team and I are studying age-related diseases, trying to find out how to prevent these diseases from occurring by preventing protein aggregation, a key factor in the development of age-related diseases.
Ultimately, we hope that our IMRIC research will not only translate into slowing down the degenerative process, but prevent it entirely.
B.Sc. and M.Sc., the Hebrew University of Jerusalem
Post-Doctorate: The Salk Institute for Biological Studies, San Diego, CA
Independent lab studies, the Hebrew University Medical School
In our IMRIC lab, we are trying to solve a puzzle.
We know that in the course of a cell's lifetime, toxins build up which can impair or drastically alter cellular function. But the real puzzle is why some toxins only start to build up late in life. For example, members of families with a history of Alzheimer's disease seem to develop it at around the same age — late in life. Where is the disease until then?
Winnipeg Jewish Review Article - "Hebrew U Prof: In Order To Understand Alzehimer's Disease You Have To Think Of Chicken Soup"
by Rhonda Spivak, posted Dec 20, 2011
In order to understand Alzheimer’s disease, you have to think of chicken soup!
When you make chicken soup, you get all those oil drops that start to form together until you get one big glob of fatty oil. This happens when the oil drops form aggregates.
Haaretz Article on IMRIC Researchers: "Israeli Scientists Discover Substance That May Fend Off Alzheimer's, Aging"
Israeli researchers at The Institute for Medical Research Israel-Canada (IMRIC) at Hebrew U say a new material they are developing that inhibits the aging process could prevent degenerative diseases without affecting lifespan.
A step toward development of drugs for diseases like Alzheimer's, Parkinson's and Huntington's
IMRIC Scientists Say Alzheimer's Is Probably A Collection Of Diseases That Should Be Classified And Treated Separately
Deciphering the mechanism that underlies the development of Alzheimer's disease in certain families but not in others, researchers at the Hebrew University of Jerusalem’s Faculty of Medicine have proposed that the malady is actually a collection of diseases that probably should be treated with a variety of different approaches.
Discussed collaborative medical research partnerships between Canada and Israel at IMRIC, the Institute for Medical Research Israel-Canada. Mrs. Johnston Visited Early Childhood Programs at Hebrew University.